전남대학교 중앙도서관

  • 중앙도서관
  • 여수캠퍼스도서관
  • 법학도서관
  • 치의학도서관
  • 의학도서관

링크메뉴

  • 화면키우기 화면줄이기 화면크기 원래대로
  • S
  • HOME
  • 로그인
  • 전남대
  • ENG
  • CHN

주메뉴

전체메뉴

전자자료 상세검색

전자자료 상세검색

통합검색
상세검색
검색어 [키워드: "Lillie PJ"]
총 38건 
※ 중복 레코드가 제거된 검색 결과가 표시됩니다.
1/4 페이지 RSS 엑셀파일 출력
검색결과수정
  • 검색범위확장
    • Full Text내 키워드 확장
    • 관련 주제어 확장

    재검색

  • 검색결과제한
    • 원문(Full Text)
    • Peer-Reviewed 학술지
    • 발행년 -

    재검색

  • 자료유형
    • Academic Journals (38)

    재검색

  • 주제
    • covid-19 (7)
    • influenza, human (6)
    • covid-19 vaccines (5)

    더보기

    재검색

  • 간행물
    • journal of infection (7)
    • lancet london england (4)
    • clinical infectious diseases an official publication of the infectious diseases society of america (3)

    더보기

    재검색

  • 출판사
    • elsevier (7)
    • oxford university press (5)
    • w.b. saunders (5)

    더보기

    재검색

  • 언어
    • english (38)

    재검색

  • 수록데이터베이스
    • MEDLINE (35)
    • CINAHL Plus with Full Text (2)
    • Supplemental Index (1)

    재검색

  • PQDTSearch
  • CAJSearch
  • RISSSearch
  • PsycINFOSearch

 

3
Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial. 미리보기

학술저널

issue
The Lancet. Infectious diseases [Lancet Infect Dis] 2023 Sep; Vol. 23 (9), pp. 1007-1019. Date of Electronic Publication: 2023 Jun 19.
Author
Lee IT; Moderna, Cambridge, MA, USA. Electronic address: ivan.lee@modernatx.com.
Cosgrove CA; Vaccine Institute, Centre for Neonatal and Paediatric Infection, St George's University of London, London, UK.
Moore P; Adam Practice, Poole, UK; University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Bethune C; University Hospitals Plymouth NHS Trust, Plymouth, UK.
Nally R; Wansford and Kings Cliffe Practice, Wansford, UK.
Bula M; Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK.
Kalra PA; Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK.
Clark R; Layton Medical Centre, Blackpool, UK.
Dargan PI; Guy's & St Thomas' NHS Foundation Trust, King's College London, London, UK.
Boffito M; Chelsea and Westminster Hospital NHS Foundation Trust, London, UK; Department of Infectious Disease, Imperial College London, London, UK.
Sheridan R; Royal Devon University Hospital, Exeter, UK.
Moran E; Southmead Hospital, Bristol, UK.
Darton TC; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Burns F; Royal Free London NHS Foundation Trust University and University College London, London, UK.
Saralaya D; National Institute for Health Research Patient Recruitment Centre, Bradford, UK; Bradford Teaching Hospitals NHS Foundation Trust, Bradford, UK.
Duncan CJA; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK; NIHR Newcastle Clinical Research Facility, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Lillie PJ; Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital, Cottingham, UK.
San Francisco Ramos A; Vaccine Institute, Centre for Neonatal and Paediatric Infection, St George's University of London, London, UK.
Galiza EP; Vaccine Institute, Centre for Neonatal and Paediatric Infection, St George's University of London, London, UK.
Heath PT; Vaccine Institute, Centre for Neonatal and Paediatric Infection, St George's University of London, London, UK.
Girard B; Moderna, Cambridge, MA, USA.
Parker C; Moderna, Cambridge, MA, USA.
Rust D; Moderna, Cambridge, MA, USA.
Mehta S; Moderna, Cambridge, MA, USA.
de Windt E; Moderna, Cambridge, MA, USA.
Sutherland A; Moderna, Cambridge, MA, USA.
Tomassini JE; Moderna, Cambridge, MA, USA.
Dutko FJ; Moderna, Cambridge, MA, USA.
Chalkias S; Moderna, Cambridge, MA, USA.
Deng W; Moderna, Cambridge, MA, USA.
Chen X; Moderna, Cambridge, MA, USA.
Feng J; Moderna, Cambridge, MA, USA.
Tracy L; Moderna, Cambridge, MA, USA.
Zhou H; Moderna, Cambridge, MA, USA.
Miller JM; Moderna, Cambridge, MA, USA.
Das R; Moderna, Cambridge, MA, USA.
DB Label
Database : MEDLINE
원문보기
Full Text (ScienceDirect)  Full Text (Clinical Key)  조회 - Impact Factor (JCR)  등재 - Web of Science (SCIE) 
4
Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines. 미리보기

학술저널

issue
The Journal of infection [J Infect] 2023 Jun; Vol. 86 (6), pp. 574-583. Date of Electronic Publication: 2023 Apr 06.
Author
Shaw RH; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: robert.shaw@paediatrics.ox.ac.uk.
Greenland M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Stuart ASV; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Andrews NJ; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK.
Cameron JC; Public Health Scotland, Glasgow, Scotland, UK.
Charlton S; UK Health Security Agency, Porton Down, Salisbury, UK.
Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Collins AM; Liverpool School of Tropical Medicine, Liverpool, UK.
Darton T; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, UK; Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, UK.
Dinesh T; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Duncan CJA; The Newcastle upon Tyne Hospitals NHS Foundation Trust, UK; Translational and Clinical Research Institute, Newcastle University, UK.
Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Ferreira DM; Liverpool School of Tropical Medicine, Liverpool, UK.
Finn A; Schools of Population Health Sciences and Cellular and Molecular Medicine, University of Bristol, Bristol, UK.
Goodman AL; Department of Infection & NIHR BRC, Guy's and St Thomas' NHS Foundation Trust, UK; MRC Clinical Trials Unit, University College London, UK.
Green CA; NIHR/Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; School of Chemical Engineering, University of Birmingham, UK.
Hallis B; UK Health Security Agency, Porton Down, Salisbury, UK.
Heath PT; The Vaccine Institute, St. George's University of London, London, UK.
Hill H; Liverpool School of Tropical Medicine, Liverpool, UK.
Lambe T; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK.
Libri V; NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.
Lillie PJ; Infection Research Group, Hull University Teaching Hospitals NHS Trust, Hull, UK.
Morey E; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Mujadidi YF; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Payne R; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, UK; Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, UK.
Plested EL; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Provstgaard-Morys S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Ramsay M; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, London, UK.
Read RC; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Screaton GR; Chinese Academy of Medical Science (CAMS) Oxford Institute (COI), University of Oxford, Oxford, UK; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Singh N; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Turner DPJ; University of Nottingham, Nottingham, UK; Nottingham University Hospitals NHS Trust, Nottingham, UK.
Turner PJ; National Heart & Lung Institute, Imperial College London, London, UK.
White R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Nguyen-Van-Tam JS; Unit of Lifespan and Population Health, University of Nottingham School of Medicine, Nottingham, UK.
Liu X; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Snape MD; Oxford NIHR - Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
DB Label
Database : MEDLINE
원문보기
Full Text (ScienceDirect)  Full Text (Clinical Key)  조회 - Impact Factor (JCR)  등재 - Web of Science (SCIE) 
7
Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial. 미리보기

학술저널

issue
Lancet (London, England) [Lancet] 2022 Jan 01; Vol. 399 (10319), pp. 36-49. Date of Electronic Publication: 2021 Dec 06.
Author
Stuart ASV; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Shaw RH; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Liu X; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Greenland M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Aley PK; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Andrews NJ; Statistics, Modelling and Economics Department, UK Health Security Agency, London, UK; Immunisation and Countermeasures Division, National Infection Service, UK Health Security Agency, London, UK.
Cameron JC; Public Health Scotland, Glasgow, Scotland, UK.
Charlton S; UK Health Security Agency, Porton Down, Salisbury, UK.
Clutterbuck EA; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Collins AM; Liverpool School of Tropical Medicine, Liverpool, UK.
Darton T; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK; Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Dinesh T; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Duncan CJA; The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Translational and Clinical Research Institute, Newcastle University, Newcastle, UK.
England A; UK Health Security Agency, Porton Down, Salisbury, UK.
Faust SN; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Ferreira DM; Liverpool School of Tropical Medicine, Liverpool, UK.
Finn A; School of Population Health Sciences, and School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.
Goodman AL; Department of Infection, and NIHR BRC, Guy's and St Thomas' NHS Foundation Trust, London, UK; MRC Clinical Trials Unit, University College London, London, UK.
Green CA; NIHR/Wellcome Trust Clinical Research Facility, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK.
Hallis B; UK Health Security Agency, Porton Down, Salisbury, UK.
Heath PT; The Vaccine Institute, St George's University of London, London, UK.
Hill H; Liverpool School of Tropical Medicine, Liverpool, UK.
Horsington BM; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Lambe T; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Chinese Academy of Medical, Science Oxford Institute, University of Oxford, Oxford, UK.
Lazarus R; North Bristol NHS Trust, Bristol, UK.
Libri V; NIHR UCLH Clinical Research Facility and NIHR UCLH Biomedical Research Centre, University College London Hospitals NHS Foundation Trust, London, UK.
Lillie PJ; Infection Research Group, Hull University Teaching Hospitals NHS Trust, Hull, UK.
Mujadidi YF; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Payne R; Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK; Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK.
Plested EL; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Provstgaard-Morys S; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Ramasamy MN; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
Ramsay M; Immunisation and Countermeasures Division, National Infection Service, UK Health Security Agency, London, UK.
Read RC; NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, UK; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, UK.
Robinson H; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Screaton GR; Chinese Academy of Medical, Science Oxford Institute, University of Oxford, Oxford, UK; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Singh N; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Turner DPJ; University of Nottingham, Nottingham, UK; Nottingham University Hospitals NHS Trust, Nottingham, UK.
Turner PJ; National Heart and Lung Institute, Imperial College London, London, UK.
Vichos I; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
White R; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK.
Nguyen-Van-Tam JS; Division of Epidemiology and Public Health, University of Nottingham School of Medicine, Nottingham, UK.
Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, UK; Oxford NIHR-Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK. Electronic address: matthew.snape@paediatrics.ox.ac.uk.
DB Label
Database : MEDLINE
원문보기
Full Text (ScienceDirect)  Full Text (Clinical Key)  조회 - Impact Factor (JCR)  등재 - Web of Science (SCIE)  등재 - SCOPUS 
10
Non-communicable disease, sociodemographic factors, and risk of death from infection: a UK Biobank observational cohort study. 미리보기

학술저널

issue
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 Aug; Vol. 21 (8), pp. 1184-1191. Date of Electronic Publication: 2021 Mar 01.
Author
Drozd M; Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK.
Pujades-Rodriguez M; Leeds Institute of Health Sciences, School of Medicine, University of Leeds, Leeds, UK; IQVIA, London, UK.
Lillie PJ; Department of Infection, Castle Hill Hospital, Hull University Hospitals NHS Trust, Kingston Upon Hull, UK.
Straw S; Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK.
Morgan AW; Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK; NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Kearney MT; Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK.
Witte KK; Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK.
Cubbon RM; Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds, UK. Electronic address: r.cubbon@leeds.ac.uk.
DB Label
Database : MEDLINE
원문보기
Full Text (ScienceDirect)  Full Text (Clinical Key)  조회 - Impact Factor (JCR)  등재 - Web of Science (SCIE) 
1 2 3 4 
바구니보기

QUICK LINK

  • 희망도서신청
  • 대출/연장조회
  • 서가부재도서
  • 이용교육

마이메뉴추가

QRCode
  • 개인정보호정책
  • 이메일무단수집거부
  • 도서관이용문의

    • 도서관자치위원회  원격제어  Instagram  facebook  w  kakao 플친
500-757 광주광역시 북구 용봉로 77 TEL 062)530-3571~2(대출반납실) FAX 062)530-3529
Copyright@2013 CHONNAM NATIONAL UNIVERSITY LIBRARY, All Rights Reserved.
  • 141499
  • 127365998